Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Erector spinae plane block for abdominal pain from gastrointestinal cancer

Official title: Efficacy of the Erector Spinae Plane Block for Abdominal Pain From Gastrointestinal Malignancies

Run by Abramson Cancer Center at Penn Medicine · NCT07211386 · Data updated 2026-11-12

This study will try an erector spinae plane nerve block to reduce severe abdominal pain and opioid use in adults with gastrointestinal cancers who come to Penn Medicine emergency departments.

More Pain Control trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorAbramson Cancer Center at Penn Medicine
Academic / other
Locations4 sites (Philadelphia, Pennsylvania and 3 other locations)
StatusRecruiting
StartedDecember 11, 2025
Main results expectedMay 15, 2027
Study endsJune 15, 2027
Registry record updatedNovember 28, 2025
Trial IDNCT07211386 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) with known gastrointestinal malignancy who present to a participating Penn Medicine ED with intractable abdominal pain and a same-day or recent CT showing a malignant source, who are medically stable and able to consent, are the intended participants.

Probably not a fit

Patients with non-malignant causes of pain, hemodynamic instability, allergy to ropivacaine or history of local anesthetic toxicity, pregnancy, incarceration, inability to consent, admission for serial abdominal exams, or prior enrollment are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project will offer an erector spinae plane block (ESPB), a regional anesthetic technique, to adults with GI malignancy who present to Penn Medicine EDs with intractable abdominal pain. Eligible patients receiving ESPB will be enrolled as a prospective cohort and compared to a matched historical control group of similar patients treated with standard ED analgesia. The primary outcome is total opioid use over 24 hours measured in milligram morphine equivalents (MMEs), with secondary outcomes including hospital length of stay and pre/post-block pain, function, and satisfaction at 24 hours. The ESPB will be performed by ED providers per institutional protocols already in use at UPHS.

Why it matters

Potential benefit: If successful, the ESPB could lower opioid needs and pain levels and possibly shorten hospital stays for patients with cancer-related abdominal pain.

How similar studies have gone: Regional anesthesia techniques including ESPB have shown pain and opioid-sparing benefits in perioperative and acute pain case series and small trials, but high-quality evidence specifically for ED management of GI cancer pain is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients age \> 18 years old with GI malignancy presenting to a Penn Medicine ED with intractable abdominal pain.
2. Same-day or recent CT scan of the abdomen / pelvis which demonstrates that the patient's abdominal pain can be reasonably attributed to a malignant source.

Exclusion Criteria:

1. Allergy to ropivacaine or history of local anesthetic systemic toxicity.
2. Pregnancy
3. Incarcerated
4. Patients being admitted for serial abdominal examinations to determine their surgical course.
5. Altered mental status or inability for patient to consent for the procedure
6. Hemodynamic instability
7. Previously enrolled in the study

Where it's running

  • Hospital of the University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Penn Presbyterian Medical Center
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Pennsylvania Hospital
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Hospital of the University of Pennsylvania -- Cedar Avenue
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.